Clinical Trial Update: Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia [Phase 3]

View source ↗

Summary

Phase 3 trial updates for LNZ101 and LNZ100 in presbyopia have completed evaluating their efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Presbyopia

Drugs mentioned

• LNZ100 (Aceclidine)
• LNZ101 (Aceclidine/Brimonidine)

Snippet

Sponsor: Corxel Pharmaceuticals | Conditions: Presbyopia, Near Vision | Phase 3 | Status: COMPLETED